Clioquinol–ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity
出版年份 2016 全文链接
标题
Clioquinol–ruthenium complex impairs tumour cell invasion by inhibiting cathepsin B activity
作者
关键词
-
出版物
DALTON TRANSACTIONS
Volume 45, Issue 42, Pages 16913-16921
出版商
Royal Society of Chemistry (RSC)
发表日期
2016-09-16
DOI
10.1039/c6dt02369j
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Inhibition of endopeptidase and exopeptidase activity of cathepsin B impairs extracellular matrix degradation and tumour invasion
- (2016) Ana Mitrović et al. BIOLOGICAL CHEMISTRY
- The development of RAPTA compounds for the treatment of tumors
- (2016) Benjamin S. Murray et al. COORDINATION CHEMISTRY REVIEWS
- Metal-based drugs that break the rules
- (2016) Claire S. Allardyce et al. DALTON TRANSACTIONS
- Interactions of Cisplatin with non-DNA Targets and their Influence on Anticancer Activity and Drug Toxicity: The Complex World of the Platinum Complex
- (2015) Roman Mezencev CURRENT CANCER DRUG TARGETS
- New mechanisms for old drugs: Insights into DNA-unrelated effects of platinum compounds and drug resistance determinants
- (2015) Laura Gatti et al. DRUG RESISTANCE UPDATES
- Combination of Ru(ii) complexes and light: new frontiers in cancer therapy
- (2015) Cristina Mari et al. Chemical Science
- Nitroxoline impairs tumor progression in vitro and in vivo by regulating cathepsin B activity
- (2015) Bojana Mirković et al. Oncotarget
- Molecular Pathways: The Immunogenic Effects of Platinum-Based Chemotherapeutics
- (2014) S. V. Hato et al. CLINICAL CANCER RESEARCH
- Structural characterization and biological evaluation of a clioquinol–ruthenium complex with copper-independent antileukaemic activity
- (2014) Martina Gobec et al. DALTON TRANSACTIONS
- The current stage of cathepsin B inhibitors as potential anticancer agents
- (2014) Janko Kos et al. Future Medicinal Chemistry
- Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy
- (2014) Suzanne Leijen et al. INVESTIGATIONAL NEW DRUGS
- Coordination of Hydroxyquinolines to a Ruthenium Bis-dimethyl-phenanthroline Scaffold Radically Improves Potency for Potential as Antineoplastic Agents
- (2014) David K. Heidary et al. JOURNAL OF MEDICINAL CHEMISTRY
- NKP-1339, the first ruthenium-based anticancer drug on the edge to clinical application
- (2014) Robert Trondl et al. Chemical Science
- Ligand substitutions between ruthenium–cymene compounds can control protein versus DNA targeting and anticancer activity
- (2014) Zenita Adhireksan et al. Nature Communications
- New Uses for Old Drugs: Attempts to Convert Quinolone Antibacterials into Potential Anticancer Agents Containing Ruthenium
- (2013) Jakob Kljun et al. INORGANIC CHEMISTRY
- MEROPS: the database of proteolytic enzymes, their substrates and inhibitors
- (2013) Neil D. Rawlings et al. NUCLEIC ACIDS RESEARCH
- Development of New Cathepsin B Inhibitors: Combining Bioisosteric Replacements and Structure-Based Design To Explore the Structure–Activity Relationships of Nitroxoline Derivatives
- (2012) Izidor Sosič et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Biological Evaluation of the Thionated Antibacterial Agent Nalidixic Acid and Its Organoruthenium(II) Complex
- (2012) Rosana Hudej et al. ORGANOMETALLICS
- Novel Mechanism of Cathepsin B Inhibition by Antibiotic Nitroxoline and Related Compounds
- (2011) Bojana Mirković et al. ChemMedChem
- Interactions of Metal Ions with DNA, Its Constituents and Derivatives, which may be Relevant for Anticancer Research
- (2011) Iztok Turel et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Reactivity study of arene(azido)ruthenium N∩O-base complexes with activated alkynes
- (2011) Saphidabha L. Nongbri et al. INORGANICA CHIMICA ACTA
- Organometallic Ruthenium(II) Arene Compounds with Antiangiogenic Activity
- (2011) Patrycja Nowak-Sliwinska et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mechanistic modeling of the effects of myoferlin on tumor cell invasion
- (2011) M. C. Eisenberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Rationalization of the inhibition activity of structurally related organometallic compounds against the drug target cathepsin B by DFT
- (2010) Angela Casini et al. DALTON TRANSACTIONS
- Organometallic Anticancer Compounds
- (2010) Gilles Gasser et al. JOURNAL OF MEDICINAL CHEMISTRY
- Arene ruthenium oxinato complexes: Synthesis, molecular structure and catalytic activity for the hydrogenation of carbon dioxide in aqueous solution
- (2009) Trieu-Tien Thai et al. JOURNAL OF ORGANOMETALLIC CHEMISTRY
- Emerging Protein Targets for Anticancer Metallodrugs: Inhibition of Thioredoxin Reductase and Cathepsin B by Antitumor Ruthenium(II)−Arene Compounds
- (2008) Angela Casini et al. JOURNAL OF MEDICINAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now